This inventor holds 3 USPTO granted patents. Top assignee: James Black Foundation Limited. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Martin Lyn Hudson: Innovator in Gastrin and CCK Receptor Ligands
Introduction
Martin Lyn Hudson is a notable inventor based in Brighton, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of receptor ligands. With a total of 3 patents to his name, Hudson's work is recognized for its potential impact on medical science.
Latest Patents
Hudson's latest patents include innovative compounds related to gastrin and CCK receptor ligands. These compounds are defined by specific formulas, wherein A represents a group having two fused rings or a group of formula (Id). The ligands are designed to interact with CCK and/or gastrin receptors, showcasing their potential therapeutic applications.
Career Highlights
Throughout his career, Martin Lyn Hudson has been associated with the James Black Foundation Limited. His work at this organization has allowed him to focus on groundbreaking research and development in the pharmaceutical sector.
Collaborations
Hudson has collaborated with esteemed colleagues such as Sarkis Barret Kalindjian and Katherine Isobel Steel. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Martin Lyn Hudson stands out as an influential inventor in the realm of gastrin and CCK receptor ligands. His contributions continue to shape the future of pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile